clavulanic acid has been researched along with Lymphoma, Non-Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elis, A; Lishner, M; Manor, Y; Shacham-Abulafia, A | 1 |
| Archer-Dubon, C; Criollo, E; Hernández-Salazar, A; Orozco-Topete, R; Rangel-Frausto, S; Rosales, SP | 1 |
2 other study(ies) available for clavulanic acid and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study].
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Clavulanic Acid; Humans; Infusions, Parenteral; Lymphoma, Non-Hodgkin; Neoplasm Staging; Neutropenia; Retrospective Studies | 2010 |
Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amphotericin B; Clavulanic Acid; Cohort Studies; Dipyrone; Drug Eruptions; Female; Hospitalization; Humans; Immune Tolerance; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Male; Mexico; Middle Aged; Prevalence; Prospective Studies | 2006 |